Our vision is to transform medical care from reactive to proactive through a plannable, Digital-Twin & AI driven treatment framework. By combining non-invasive imaging, functional assessment, and intelligent decision support, we empower clinicians to predict, personalize, and plan the optimal therapy for each patient.
Current coronary artery disease diagnostics often rely on invasive procedures or anatomical imaging alone, leading to overtreatment or missed interventions.
Tertiary hospitals performing coronary CTA or invasive angiography.
Early detection for high-risk populations with AI screening.
Cloud-based AI diagnostics without heavy infrastructure.
Bringing expert-level care to underserved regions.
Identified critical clinical demand through physician interviews
Core algorithm development with Virtonomy
Pilot study at Taiwan's leading medical center
FDA/TFDA SaMD approval for diagnostic claims
FDA clearance for treatment planning claims
Implementing cutting-edge digital twin technology for medical applications.
Schedule a demo to see how Slipstream can integrate with your clinical workflow.
Contact Our Team